Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03808922
Recruitment Status : Recruiting
First Posted : January 18, 2019
Last Update Posted : March 25, 2021
Sponsor:
Information provided by (Responsible Party):
Ansun Biopharma, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : April 30, 2021
Estimated Study Completion Date : December 31, 2023